lncRNA PAX8-AS1 suppresses cervical cancer development by regulating miR-675-3p/ <i>DCN</i> axis
ObjectiveCervical cancer (CC) is among the most prevalent malignancies globally. Public sequencing data indicate that PAX8-AS1 is associated with gynecological cancers, including CC, but its specific function and mechanism in cervical cancer remain unclear. The present study aimed to elucidate the role of PAX8-AS1 and its target axis in the CC.MethodsA total of 104 CC patients were included. The levels of PAX8-AS1, miR-675-3p, and <i>decorin</i> (<i>DCN</i>) were quantified by quantitative reverse transcription polymerase chain reaction. Survival curve and Cox regression predicted prognostic factors. Proliferation and invasion/migration were assayed by CCK-8 and Transwell in CC cell lines. The target relationship was verified by dual-luciferase reporter assay and co-transfection.ResultsPAX8-AS1 was declined in CC tumor tissue and cell lines. PAX8-AS1 was an independent prognostic factor. PAX8-AS1 expression was associated with the CC pathological including the international federation of gynecology and obstetrics staging system (FIGO), tumor size, and lymph node metastasis. Patients with higher PAX8-AS1 levels had better survival outcomes. Upregulation of PAX8-AS1 inhibited the CC cell invasion, migration, and proliferation. miR-675-3p was predicted and verified as sponged of PAX8-AS1. miR-675-3p was negatively related to PAX8-AS1. PAX8-AS1 impeded the CC cellular function by regulating miR-675-5p. <i>DCN</i> was confirmed as the target of miR-675-5p. <i>DCN</i> was negatively and positively related to miR-675-3p and PAX8-AS1, respectively. PAX8-AS1 suppressed the CC cell invasion, migration, and proliferation by targeting miR-675-3p/<i>DCN</i> axis.ConclusionIn summary, PAX8-AS1 was related to tumor progression and inhibited CC development. As a potential biomarker, PAX8-AS1 impeded CC cell invasion, migration, and proliferation by regulating the axis of miR-675-3p/<i>DCN</i>.
Authors
- Xiayang Lu (ORCID: https://orcid.org/0009-0006-2524-1443)
- Paul Y. Song (ORCID: https://orcid.org/0009-0004-3270-0324)
- Qingfen Chen (ORCID: https://orcid.org/0009-0009-2430-5216)
Institutions
- Harbin Medical University (CN)
- Wenzhou Medical University (CN)
- Northwest University (CN)
- Daqing City People's Hospital (CN)
- Hangzhou Hospital of Traditional Chinese Medicine (CN)
- Zhejiang Taizhou Hospital (CN)
- Northwest University First Hospital
Publication Details
- Journal
- The International Journal of Biological Markers
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1177/03936155251386471
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00